Inhibition of the PI3K/Akt signaling pathway reverses sorafenib‑derived chemo‑resistance in hepatocellular carcinoma

Hao Zhang(Shanghai University of Engineering Science), Hao-qiang Cao(First Hospital of Jiaxing)
Oncology Letters
April 18, 2018
Cited by 70


Related Papers